Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.
about
Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionRole of heparan sulfate in sexually transmitted infectionsHeparan sulfate-dependent enhancement of henipavirus infection.Circulating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells.Sialic acid associated with αvβ3 integrin mediates HIV-1 Tat protein interaction and endothelial cell proangiogenic activation.Differentiation induction of mouse embryonic stem cells into sinus node-like cells by suramin.Antiviral activity of micafungin against enterovirus 71.Amphotericin B Inhibits Enterovirus 71 Replication by Impeding Viral Entry.Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.Bridging the past and the future of virology: surface plasmon resonance as a powerful tool to investigate virus/host interactions.Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.Surface Plasmon Resonance Analysis of Heparin-Binding Angiogenic Growth Factors.Thiocarbamate-linked polysulfonate-peptide conjugates as selective hepatocyte growth factor receptor binders.Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses.Nucleic acid-induced potentiation of matrix metalloproteinase-9 enzymatic activity.
P2860
Q27004059-CA86E491-FCD3-4A29-8882-F99FB4A78443Q27023959-5FF7E377-58E7-48E9-89CA-A184D3CAAFD4Q35677600-8950D3D2-FE05-4014-9128-B67286EBE2E3Q35994961-C4489DB9-1CDE-457C-8635-EA1C514D9687Q36016939-D6CADAAA-8344-4633-A4F7-3BFEAD05A1DFQ36572956-54F25C15-3241-4F51-94D2-E900CFA70837Q37002620-4A811EE0-6281-4495-B16F-9AA9857DFBF2Q37243489-B8E214FB-6B04-4CBC-85DA-63D7E5E539FCQ37997765-8E56F619-E838-429C-9354-5DDD8818154CQ38001955-3DE7C569-5427-4944-95F5-E353CC18C77AQ38141148-9D53D529-BBB3-48CC-B287-1ADD6CC98FBBQ38418286-C5A03880-5A5F-48A3-9185-3A2111A1C86AQ39304663-D2EA6E8E-97F7-4342-9768-79542FABC55FQ40470584-E3E1D4F0-BAAC-4CC4-8E18-6EE2A3947DD8Q40926975-053C44E9-09B3-4C57-A6C9-221EE0E60092Q41930666-4DE71609-39D0-48D1-BE9F-BD952D68C535Q55332981-35316AD3-1DC3-4C44-9327-1E5575E060CA
P2860
Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Polyanionic drugs and viral on ...... inflammation and angiogenesis.
@en
Polyanionic drugs and viral on ...... inflammation and angiogenesis.
@nl
type
label
Polyanionic drugs and viral on ...... inflammation and angiogenesis.
@en
Polyanionic drugs and viral on ...... inflammation and angiogenesis.
@nl
prefLabel
Polyanionic drugs and viral on ...... inflammation and angiogenesis.
@en
Polyanionic drugs and viral on ...... inflammation and angiogenesis.
@nl
P2860
P921
P1433
P1476
Polyanionic drugs and viral on ...... inflammation and angiogenesis
@en
P2093
Chiara Urbinati
Paola Chiodelli
P2860
P304
P356
10.3390/MOLECULES13112758
P407
P577
2008-11-06T00:00:00Z